Skip to main content
Advertisement
Advertisement

BHVN

BHVN logo

Biohaven Ltd.

13.62
USD
Sponsored
-0.27
-1.94%
Sep 18, 15:59 UTC -4
Closed
exchange

After-Market

13.40

-0.21
-1.58%

BHVN Earnings Reports

Positive Surprise Ratio

BHVN beat 5 of 16 last estimates.

31%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.77
Implied change from Q2 26 (Revenue/ EPS)
--
/
-15.38%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-53.05%

Biohaven Ltd. earnings per share and revenue

On Aug 10, 2026, BHVN reported earnings of -0.91 USD per share (EPS) for Q2 26, missing the estimate of -0.74 USD, resulting in a -21.67% surprise. Revenue reached --, compared to an expected 546.17 thousand, with a -100.00% difference. The market reacted with a -0.34% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -0.77 USD, with revenue projected to reach -- USD, implying an decrease of -15.38% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
logo
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
logo
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
For Q2 2026, Biohaven Ltd. reported EPS of -$0.91, missing estimates by -21.67%, and revenue of $0.00, -100% below expectations.
The stock price moved down -0.34%, changed from $14.54 before the earnings release to $14.49 the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on 11 analysts, Biohaven Ltd. is expected to report EPS of -$0.77 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement